Thorne Healthtech Inc Quick Ratio (THRN) starting from the second quarter 2023 to second quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Thorne Healthtech Inc   (NASDAQ: THRN)

Thorne Healthtech Inc 's Quick Ratio

THRN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2023, Quick Ratio fell to 0.3 a new company low.

Within Major Pharmaceutical Preparations industry 499 other companies have achieved higher Quick Ratio than Thorne Healthtech Inc in second quarter 2023. While Quick Ratio total ranking in the second quarter 2023 has deteriorated compared to the prior quarter from 2659 to 3296.

Explain Quick Ratio?
How much Cash & cash equivalents THRN´s has?
What are THRN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

THRN Quick Ratio (Jun 30 2023)
Q2		 (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2
Y / Y Current Liabilities Change 62.71 % 17.88 % 55.77 % -38.2 % 200.42 %
Y / Y Cash & cash equivalent Change -38.54 % -64.78 % -29.5 % -70.65 % 82.22 %
Quick Ratio MRQ 0.3 0.35 0.9 0.78 0.8
THRN's Total Ranking # 3296 # 2659 # 1925 # 2279 # 1876
Seq. Current Liabilities Change 76.28 % -20.41 % 38.38 % -16.19 % 27.72 %
Seq. Cash & cash equivalent Change 54.53 % -69.29 % 60.05 % -19.06 % -11.44 %



Quick Ratio second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 500
Healthcare Sector # 965
Overall Market # 3296


Quick Ratio Statistics
High Average Low
1.99 0.99 0.3
(Dec 31 2021)   (Jun 30 2023)




Financial Statements
Thorne Healthtech Inc 's Current Liabilities $ 56 Millions Visit THRN's Balance sheet
Thorne Healthtech Inc 's Cash & cash equivalent $ 17 Millions Visit THRN's Balance sheet
Source of THRN's Sales Visit THRN's Sales by Geography


Cumulative Thorne Healthtech Inc 's Quick Ratio

THRN's Quick Ratio for the trailling 12 Months

THRN Quick Ratio

 (Jun 30 2023)
12 Months		 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth 17.1 % 21.9 % 55.36 % 99.27 % 1066.71 %
Y / Y Cash & cash equivalent TTM Growth -53.64 % -44.17 % -17.69 % 44.45 % 1125.29 %
Quick Ratio TTM 0.55 0.72 0.9 1.14 1.39
Total Ranking TTM # 4608 # 4061 # 4124 # 4076 # 4044
Seq. Current Liabilities TTM Growth 15.99 % 3.7 % 12.34 % -13.34 % 20.74 %
Seq. Cash & cash equivalent TTM Growth -11 % -17.28 % -11.35 % -28.97 % 7.19 %

Quick ratio ranking by company, industry and sector >> Back to THRN Financial Strength Comparisons >> Go to Compare THRN Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q2 2023 to $56.25 millions, cumulative Quick Ratio decreased to 0.55 below the Thorne Healthtech Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 578 other companies have achieved higher Quick Ratio than Thorne Healthtech Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2023 from 4061 to 4608.

Explain Quick Ratio?
How much Cash & cash equivalents THRN´s has?
What are THRN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 579
Healthcare Sector # 1164
Within the Market # 4608


trailing twelve months Quick Ratio Statistics
High Average Low
1.39 1 0.55
(Jun 30 2022)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Kineta Inc   0.83 $ 7.770  Millions$ 9.369  Millions
Celyad Oncology Sa  0.82 $ 5.434  Millions$ 6.652  Millions
Citius Oncology Inc  0.81 $ 0.370  Millions$ 0.459  Millions
Cellectar Biosciences Inc   0.81 $ 5.153  Millions$ 6.392  Millions
Medicure Inc   0.80 $ 4.879  Millions$ 6.077  Millions
Ascendis Pharma A  0.80 $ 431.976  Millions$ 541.586  Millions
Maravai Lifesciences Holdings Inc   0.79 $ 580.176  Millions$ 730.376  Millions
Pharming Group N v   0.79 $ 61.741  Millions$ 77.968  Millions
Xencor Inc  0.78 $ 34.710  Millions$ 44.630  Millions
Phibro Animal Health Corporation  0.77 $ 81.281  Millions$ 105.597  Millions
Blue Water Vaccines Inc  0.76 $ 9.223  Millions$ 12.134  Millions
Applied Therapeutics Inc   0.75 $ 35.616  Millions$ 47.188  Millions
Elite Pharmaceuticals Inc   0.75 $ 9.098  Millions$ 12.078  Millions
Collegium Pharmaceutical Inc   0.75 $ 325.470  Millions$ 435.058  Millions
Johnson and Johnson  0.74 $ 28,505.000  Millions$ 38,498.000  Millions
Intercept Pharmaceuticals inc   0.73 $ 136.229  Millions$ 187.022  Millions
Stablecoin Development Corporation  0.73 $ 4.414  Millions$ 6.066  Millions
Theratechnologies Inc   0.72 $ 34.097  Millions$ 47.294  Millions
Ptc Therapeutics inc   0.71 $ 337.943  Millions$ 476.342  Millions
Vbi Vaccines Inc  0.69 $ 20.840  Millions$ 29.998  Millions
Kazia Therapeutics Limited  0.69 $ 5.241  Millions$ 7.565  Millions
Cumberland Pharmaceuticals Inc   0.69 $ 18.249  Millions$ 26.638  Millions
Panbela Therapeutics Inc   0.68 $ 7.205  Millions$ 10.555  Millions
Urogen Pharma Ltd   0.68 $ 20.128  Millions$ 29.765  Millions
Fortress Biotech Inc   0.67 $ 86.772  Millions$ 128.583  Millions
Clever Leaves Holdings Inc   0.67 $ 5.077  Millions$ 7.562  Millions
Prophase Labs Inc   0.67 $ 9.104  Millions$ 13.675  Millions
Nrx Pharmaceuticals Inc   0.66 $ 14.969  Millions$ 22.617  Millions
Amphastar Pharmaceuticals Inc   0.66 $ 165.336  Millions$ 251.285  Millions
Inventiva S a   0.64 $ 36.142  Millions$ 56.177  Millions

Date modified: 2026-08-29T17:45:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.